Maribavir
SHP620-302
Phase 3 small_molecule completed
Quick answer
Maribavir for Cytomegalovirus (CMV) is a Phase 3 program (small_molecule) at Shire with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Shire
- Indication
- Cytomegalovirus (CMV)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed